Overview
- 95 inspections across 75 sites are on record.
- 368 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-11-14.
At a glance
Inspections
95
Sites
75
Observations
368
Career since
Jul 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Roche Singapore Technical Operations Pte. Ltd. | 14 Nov 2025 | Human Drugs | On file |
| Zoetis LLC | 13 Feb 2024 | Animal Drugs & Feeds | View 483 → |
| King Pharmaceuticals LLC | 21 Oct 2019 | Human Drugs | View 483 → |
| Catalent Indiana, LLC | 19 May 2017 | Medical Devices & Rad Health | View 483 → |
| Cardinal Health 414, LLC | 9 Dec 2016 | Human Drugs |
Sites inspected
Roche Singapore Technical Operations Pte. Ltd.Singapore, Singapore1 insp.
Zoetis LLCKalamazoo, United States1 insp.
King Pharmaceuticals LLCRochester, United States1 insp.
Catalent Indiana, LLCBloomington, United States1 insp.
Cardinal Health 414, LLCIndianapolis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rebecca E Dombrowski9 shared
Michele L Forster9 shared
Emily J Orban7 shared
Andrew J Idzior5 shared
Sarah M Napier4 shared
Sarah M Meng4 shared
Patsy J Domingo4 shared
Robert M Barbosa3 shared
Sneha S Patel3 shared
Jacob G Lutz2 shared
Full investigator report
Get the verbatim findings behind Jeffrey D Meng's 368 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site